Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Express Scripts
Merck
Dow
Deloitte
US Army
Citi
Queensland Health

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019762

« Back to Dashboard

NDA 019762 describes TESTODERM, which is a drug marketed by Alza and is included in two NDAs. There is one patent protecting this drug. Additional details are available on the TESTODERM profile page.

The generic ingredient in TESTODERM is testosterone. There are sixty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 019762
Tradename:TESTODERM
Applicant:Alza
Ingredient:testosterone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019762

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength4MG/24HR
Approval Date:Oct 12, 1993TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength6MG/24HR
Approval Date:Oct 12, 1993TE:RLD:No

Expired US Patents for NDA 019762

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-002 Oct 12, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-001 Oct 12, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-001 Oct 12, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Alza TESTODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 019762-001 Oct 12, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Chinese Patent Office
Harvard Business School
Julphar
Dow
Express Scripts
Argus Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.